Pharmaceutical Advertising 2025

Chambers and Partners, 2025 Online Journal

The article "Pharmaceutical Advertising 2025 | Switzerland" from Chambers and Partners provides an overview of the regulatory environment for pharmaceutical advertising in Switzerland1. It highlights the ban on pre-approval promotion and direct-to-consumer (DTC) advertising of prescription medicines2. The article also discusses the narrow limits for permissible pharmaceutical advertising, which depend largely on legal and regulatory expertise as well as extensive practical industry experience2. Additionally, it covers the latest developments and compliance issues in the pharmaceutical advertising sector, offering valuable insights for professionals in the field.